These findings indicate that Act1 modulates IL-23/IL-21-dependent autoimmunity via suppression of STAT3 activation, providing a mechanism for the association of the SNP-D10N mutation with SLE. This evidence concerns the gene IL21 and systemic lupus erythematosus.